Immunotec Announces Change in Marketing Management

Immunotec Inc. (TSX VENTURE:IMM), a Canadian based company and a leader in the
wellness industry (the "Company") today announced that Mr. Daniel Audet,
Vice-President, Marketing, will be leaving Immunotec effective March 11, 2014 to
pursue new opportunities. 


To enable smooth operational functioning and an orderly evaluation of
organizational needs, Ms. Kim Hayes will serve as Senior Director of Marketing
with accountability for all marketing functions. Ms. Hayes will report to JP
Trottier, Vice-President of Field Development. 


"Over the past three years, Mr. Audet and his team have made significant
contributions to advancing Immunotec's performance and it is with appreciation
that we wish all the best to Daniel in his future endeavors", said Mr. Charles
L. Orr, Chief Executive Officer. "Ms. Hayes, as Director of Programs and
Recognition, had the lead responsibility for delivering the 2014 Convention in
Santa Fe, Mexico, 2013 Incentive Trip and 2013 Barbecue, all highly successful
activities. Ms. Hayes is a strong, knowledgeable leader and I am certain that
she will be able to make an immediate positive impact on Immunotec's marketing
activities."


About Immunotec Inc. 

Immunotec Inc. is dedicated to making a positive difference in people's
lifestyle every day by offering research-driven nutritional products through its
network of Independent Consultants worldwide. Immunotec's strength comes from
its culture that emphasizes teamwork and entrepreneurial leadership by
employees, consultants and research collaborators. 


Headquartered with manufacturing facilities near Montreal, Canada, Immunotec
Consultants generate nearly $55.0 Million in annual revenues. Please visit us at
www.immunotec.com for additional information. 


The Company files its consolidated financial statements, its management and
discussion analysis report, its press releases and such other required documents
on the SEDAR database at www.sedar.com and on the Company's website at
www.immunotec.com. The common shares of the Company are listed on the TSX
Venture Exchange under the ticker symbol IMM. Neither TSX Venture Exchange nor
its Regulation Services Provider (as that term is defined in policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or accuracy of this
release. 


CAUTION REGARDING FORWARD-LOOKING STATEMENTS: Certain statements contained in
this news release are forward looking and are subject to numerous risks and
uncertainties, known and unknown. For information identifying known risks and
uncertainties and other important factors that could cause actual results to
differ materially from those anticipated in the forward-looking statements,
please refer to the heading Risks and Uncertainties in Immunotec's most recent
Management's Discussion and Analysis, which can be found at www.sedar.com.
Consequently, actual results may differ materially from the anticipated results
expressed in these forward-looking statements.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Patrick Montpetit CPA, CA, CF
Vice-President and Chief Financial Officer
Immunotec Inc.
[phone]